Veterinary/Animal Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Veterinary/Animal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Veterinary/Animal Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Other Vaccines
Segment by Application
- Hospitals and Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
By Company
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim
- Elanco
- Virbac
- Vetoquinol
- Phibro Animal Health
- Hester
- Hipra
- Idt Biologika
- Biogenesis Bago
- Tianjin Ringpu
- China Animal Husbandry
